Amy Quinn
Impact in
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Genomics and Chromatin Dynamics
- Applied Psychology top 10%
Papers in
- Co-authors
- Anton SimeonovT.M. PenningRonald G. HarveyAjit JadhavJoel MeyersDaryl R. Van TongerenEverett L. WorthingtonBrandon J. Griffin
- Journals
- Chemical Research in Toxicology (4 papers)SLAS DISCOVERY (2 papers)Molecular BioSystems (2 papers)British Journal of Haematology (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomChile
In The Last Decade
Amy Quinn
29 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 994
- Applied Psychology 69
- Social Psychology 235
- Cancer Research 140
- Clinical Psychology 191
Countries citing papers authored by Amy Quinn
This map shows the geographic impact of Amy Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Quinn more than expected).
Fields of papers citing papers by Amy Quinn
This network shows the impact of papers produced by Amy Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Quinn. The network helps show where Amy Quinn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Quinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2017 | 33 | |
| 3 | Thankful for the little things: A meta-analysis of gratitude interventions. Hit paper breakdown → | 2015 | 299 |
| 4 | 2013 | 234 | |
| 5 | 2013 | 8 | |
| 6 | Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity | 2013 | 25 |
| 7 | 2012 | 13 | |
| 8 | 2012 | 16 | |
| 9 | 2011 | 8 | |
| 10 | 2010 | 43 | |
| 11 | 2010 | 64 | |
| 12 | 2010 | 173 | |
| 13 | 2009 | 76 | |
| 14 | 2009 | 56 | |
| 15 | 2009 | 41 | |
| 16 | 2008 | 71 | |
| 17 | 2006 | 1 | |
| 18 | 2005 | 9 | |
| 19 | 2003 | 3 | |
| 20 | Made in America: His Own Story | 1985 | 12 |
About Amy Quinn
Amy Quinn is a scholar working on Issues, ethics and legal aspects, Medical Laboratory Technology, Cell Biology, Toxicology and Molecular Biology, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Histone Deacetylase Inhibitors Research (6 papers), Cancer-related gene regulation (6 papers), Aldose Reductase and Taurine (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Prenatal Substance Exposure Effects (3 papers), Genomics and Chromatin Dynamics (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Molecular Biology (994 citations), Applied Psychology (69 citations), Social Psychology (235 citations), Cancer Research (140 citations) and Clinical Psychology (191 citations). Amy Quinn has collaborated with scholars based in United States, United Kingdom and Chile. Frequent co-authors include Anton Simeonov, T.M. Penning, Ronald G. Harvey, Ajit Jadhav, Joel Meyers, Daryl R. Van Tongeren, Everett L. Worthington, Brandon J. Griffin, Elise Choe and Joshua N. Hook. Their work appears in journals such as Chemical Research in Toxicology, SLAS DISCOVERY, Molecular BioSystems, British Journal of Haematology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.